ASHM Report Back

Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.

Subscribe to this list via RSS Blog posts tagged in GS-7340

The renal effects of tenofovir were associated with blood levels (abstract 603) at the conference. Another presentation (abstract 103) examined a prodrug of tenofovir, GS-7340, in a 10 day monotherapy study. This produg was associated with 88% lower plasma levels of tenofovir than when the currently prescribed prodrug TDF (tenofovir disproxil fumarate) was administered. It was highly potent and is likely to be studied further as an alternative to TDF.

Tagged in: CROI2012 GS-7340

RT @SWOPnsw: "New Australia-first research into the experiences of trans and gender diverse people in the health system, including cancer c…

ASHM ASHM

RT @KirbyInstitute: “Health systems must meet the specific sexual health needs of gender-diverse communities. Not adequately accounting for…

ASHM ASHM

RT @thisnewman: I was recently reminded I had made an assumption about the pronouns of a new GP, as I hadn't thought to ask, and never have…

ASHM ASHM